A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis

Clinical trial NCT07632976 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07632976
Sponsor: Shanghai Lanyi Therapeutics Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Antiphospholipid Syndrome (APS)Thrombosis

Start date: 2026-05-25
Primary completion: 2027-09-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.